Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner
暂无分享,去创建一个
H. Shan | Z. Du | Ying-zhun Chen | Haihai Liang | Tongzhu Jin | Yingying Guo | Xiangfu Sun | T. Zhu | Xuelian Li | Di Zhu | Tong Yu | Jun-Tian Xue | Hui-Chuan Cao | Lu Ma | Yanyan Liu
[1] D. Cheng,et al. YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression , 2021, Cell Death & Disease.
[2] S. Batra,et al. RNA-based therapies: A cog in the wheel of lung cancer defense , 2021, Molecular Cancer.
[3] P. Zhu,et al. Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export. , 2021, Cell metabolism.
[4] K. Guan,et al. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine , 2020, Nature Reviews Drug Discovery.
[5] X. Cui,et al. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma , 2020, Cell Death & Disease.
[6] I. Soto-Cruz,et al. Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes , 2020, Cancers.
[7] F. Cai,et al. Epigenetic regulation of the Warburg effect by H2B monoubiquitination , 2019, Cell Death & Differentiation.
[8] Shannon M. White,et al. A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas. , 2019, Developmental cell.
[9] Wei Wei,et al. Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics , 2019, Nature Communications.
[10] K. Guan,et al. The Hippo Pathway: Biology and Pathophysiology. , 2019, Annual review of biochemistry.
[11] Ying-jian Liang,et al. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma. , 2019, Cancer letters.
[12] R. An,et al. Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP. , 2019, Cellular signalling.
[13] Ja Hyun Koo,et al. Interplay between YAP/TAZ and Metabolism. , 2018, Cell metabolism.
[14] R. De Maria,et al. The Hippo pathway in normal development and cancer , 2018, Pharmacology & therapeutics.
[15] H. Shan,et al. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD , 2018, Cell Death & Disease.
[16] Robert A. Weinberg,et al. EMT in cancer , 2018, Nature Reviews Cancer.
[17] Hongbing Zhang,et al. Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis , 2018, Cell Death & Differentiation.
[18] Marc W Kirschner,et al. Conformational Landscape of the p28-Bound Human Proteasome Regulatory Particle. , 2017, Molecular cell.
[19] Z. Xuan,et al. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition , 2017, Nature Communications.
[20] Ying Sun,et al. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway , 2016, Oncotarget.
[21] John M. Asara,et al. Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth , 2016, Nature Cell Biology.
[22] Tao Luo,et al. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression , 2016, Autophagy.
[23] Stefano Piccolo,et al. YAP/TAZ at the Roots of Cancer. , 2016, Cancer cell.
[24] R. Bast,et al. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway , 2016, Oncogene.
[25] Hong-Yang Wang,et al. Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma , 2016, The Journal of experimental medicine.
[26] S. Dupont,et al. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways. , 2016, Trends in cell biology.
[27] W. Fang,et al. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway , 2015, Journal of Hematology & Oncology.
[28] G. Halder,et al. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment , 2013, Nature Reviews Drug Discovery.
[29] W. Harris,et al. Metabolism in physiological cell proliferation and differentiation. , 2013, Trends in cell biology.
[30] Chi V. Dang,et al. Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.
[31] Jing Fu,et al. Oncoprotein p28GANK binds to RelA and retains NF-κB in the cytoplasm through nuclear export , 2007, Cell Research.
[32] T. Sakurai,et al. The oncoprotein gankyrin interacts with RelA and suppresses NF-κB activity , 2007 .
[33] Katsuhiko Itoh,et al. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas , 2000, Nature Medicine.
[34] T. Klaenhammer,et al. Application of electroporation for transfer of plasmid DNA to Lactobacillus, Lactococcus, Leuconostoc, Listeria, Pediococcus, Bacillus, Staphylococcus, Enterococcus and Propionibacterium , 1988, Molecular microbiology.